AlphaSimPlex Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

AlphaSimPlex Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-64,215	Closed	-$1.2M	–	90
2022 Q1	$1.2M	Buy	64,215 +12,380	+24%	+$223K	4.4%	2
2021 Q4	$1.11M	Buy	+51,835	New	+$1.02M	1.89%	12

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AlphaSimPlex Group's OCDX Position: Q2 2022 in Review

AlphaSimPlex Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 64,215 shares — an estimated $1.2M sold.

AlphaSimPlex Group first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $1.2M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

AlphaSimPlex Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
AlphaSimPlex Group sold 64,215 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.2M.
AlphaSimPlex Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
AlphaSimPlex Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.2M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on AlphaSimPlex Group's 13F filing for Q2 2022, filed 10 Aug 2022.